Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry v3.6.6 was added to the record history, replacing the previous v3.6.5 entry. This indicates an updated submission to the study record.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedA new page revision v3.6.5 was added to the study record history, replacing the prior v3.6.4 entry.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history log now includes a new revision entry v3.6.4. The previous v3.6.3 entry has been replaced, signaling an update to the study record's versioning.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry (v3.6.3) was added to the study history, replacing the previous revision (v3.6.2) and updating the record's documentation.SummaryDifference0.1%

- Check81 days agoChange DetectedThe history shows a new revision tag v3.6.2 was added and v3.6.0 removed, representing an administrative update to the record rather than substantive changes to the trial.SummaryDifference0.1%

- Check96 days agoChange DetectedRecruitment status updated to No longer looking for participants. The history also shows a new Revision: v3.6.0 and the removal of the previous Revision: v3.5.5.SummaryDifference0.5%

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.